Agentic Brew Daily

The Hangzhou Intermediate People's Court upheld a ruling that a tech company unlawfully terminated a QA supervisor named Zhou after he refused a 40% pay cut tied to AI replacement. The judges classified AI adoption as a voluntary business choice — not a 'major change in objective circumstances' that would let the company off the hook under China's Labor Contract Law. It's the second such ruling in six months, and Beijing released it as a 'typical case' right before International Workers' Day, which means lower courts nationwide are now expected to follow.

Why it matters: This reframes the entire economics of automation: the costs of retraining, reassignment, and severance get pushed onto employers rather than workers. With ~78,000 global tech jobs erased in the first four months of 2026 (nearly half blamed on AI), every Western layoff announcement now has a sharper political contrast to live next to. Beijing is essentially using its judiciary as a shock absorber while urban youth unemployment sits at 15.3%.

April 29 produced the most explicit AI-trade verdict so far. Alphabet popped 7-10% on Google Cloud's 63% YoY growth, Amazon rallied on AWS hitting its fastest growth in 15 quarters, while Meta dropped ~6% and Microsoft sat flat despite Azure +40%. Combined 2026 capex from Alphabet, Amazon, Meta, and Microsoft now lands at up to $665B (75% above 2025), with Wall Street modeling 2027 above $1 trillion. The community math is brutal: justifying $400B at 25% margins and 10% depreciation needs roughly $160B in incremental annual AI revenue. Reported AI revenue in 2025? Around $20B.

Why it matters: Investors are no longer buying 'AI' as a concept — each quarterly print is now a referendum on whether a specific hyperscaler can convert GPUs into ad or cloud revenue. Big Tech FCF could decline up to 90% in 2026 if the spend pace holds, and 57% of economists in a Deutsche Bank survey already flag the AI bubble as the #1 market risk. If you're building on these clouds, the question of which ones can actually keep this pace stops being academic.

Anthropic shipped Opus 4.7 on April 16 with the usual pitch: better software engineering, vision, instruction following, same $5/M input / $25/M output pricing. The consumer moment was instant — 'i know literally NOTHING about coding... and i just built 3 fully functioning web apps in 30 minutes' hit 3K engagement on X. But heavy users tell a different story: 4.7 is more confident and more wrong, and one widely-shared post announced a defection to Codex after 13 months on Claude. Token economics flipped too — one head-to-head had Opus 4.7 burning ~173K tokens on a task GPT-5.5 finished in ~82K.

Why it matters: The model layer is still strong — devs prefer Claude's output ~67% of the time in blind review. But 65% of them reach for Codex daily. The harness is winning. If you live in agentic coding tools, the lesson is that CLI ergonomics, async patterns, and token efficiency are now strategic moats — not the model's MMLU score.

A Harvard-led study published in Science on April 30 found that o1-preview matched or exceeded attending physicians on real Beth Israel ED cases across triage, admission, and long-term treatment. On 76 actual cases, o1 hit 67.1% triage accuracy versus 55.3% and 50.0% for two attendings. The gap exploded on five complex long-term treatment scenarios: 89% vs 34%. The model only saw text — no imaging, no exam, no patient in the room.

Why it matters: AI's lead is widest on the cognitively richest task — multi-step longitudinal planning — and narrowest on acute triage uncertainty. That suggests reasoning models are genuinely good at structured medical reasoning chains, not just pattern-matching. The catch: there is no formal accountability framework. When an AI-recommended diagnosis is wrong, who eats the malpractice — physician, hospital, or vendor? The authors pitch a triadic patient + doctor + AI model, but Wei Xing's caution is the one to hold onto: 'It does not demonstrate that AI is safe for routine clinical use.'